Stem Cell Wounds Therapy Global Market Report 2025
상품코드:1889593
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
줄기세포 상처 치료 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 40억 1,000만 달러로 평가되었고, 2025년에는 44억 6,000만 달러에 달할 것으로 추정되며, CAGR 11.4%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 만성 상처의 유병률 증가, 재생 의료에 대한 인지도 향상, 첨단 상처 케어 제품에 대한 수요 증가, 노인 인구 증가, 의료비 지출 증가 등의 요인과 관련이 있습니다.
줄기세포 상처 치료 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 67억 8,000만 달러에 달할 것으로 예측되며, CAGR 11.0%로 성장할 전망입니다. 예측 기간의 성장은 줄기세포 기반 치료법의 채용 확대, 재생의료 투자 증가, 협력관계 및 파트너십 증가, 세포 치료 기술 혁신의 진전, 맞춤형 의료에 대한 관심 증가에 의해 견인될 수 있습니다. 예측 기간 주요 동향으로는 줄기세포 전달 시스템의 기술적 진보, 상처 치료용 생체 재료의 혁신, 스캐폴드 기반 치료 개발, 합성 줄기세포의 연구 개발, 자동화 줄기세포 제조 기술의 진전 등을 들 수 있습니다.
만성 질환의 발생률 상승은 줄기세포 상처 치료 시장의 성장을 가속할 것으로 예측됩니다. 만성 질환은 일반적으로 천천히 진행되고 지속적인 의료 관리가 필요하거나 일상 생활을 제한하는 장기 상태를 의미합니다. 이러한 질환 증가는 주로 고령화 사회에 기인하고 있으며, 노인은 면역력의 저하나 리스크 요인에 대한 누적적인 노출에 의해 건강상 합병증을 일으키기 쉬워집니다. 줄기세포 상처 치료는 표준 치료로는 치유되지 않는 상처에 대한 재생의료 솔루션을 제공함으로써 이 증가하는 의료 요구에 대응합니다. 예를 들어, 2025년 4월에 벨기에에 본거지를 둔 비영리 단체인 국제 당뇨병 연합(IDF)이 발표한 보고서에 의하면, 2024년 기준에서 5억 8,900만 명이 당뇨병을 앓고 있으며, 2050년까지 8억 5,300만 명으로 증가할 것으로 예측되고 있습니다. 이 결과, 만성질환 증가하는 부담이 줄기세포 상처 치료 시장을 추진하고 있습니다.
주요 기업은 상처 치유 촉진, 조직 재생 개선, 만성 상처와 관련된 합병증 완화를 목표로 한 혁신적인 동종 줄기세포 치료를 개발 중입니다. 동종 치료는 기증자 유래 또는 실험실에서 배양된 줄기세포를 사용합니다. 이들 세포는 사전에 제조 및 보존이 가능하며, 환자 고유의 세포 채취를 필요로 하지 않고 복수의 환자에게 투여할 수 있습니다. 예를 들어, 2025년 4월에는 영국에 거점을 두고 있는 임상 단계의 생명공학 기업인 Cytora Limited가 당뇨병성 발궤양을 위한 기제 동종 줄기세포 치료 'hOMSC200'의 I/IIa상 임상시험에서 좋은 결과를 보고했습니다. 본 요법은 수용자에서의 면역반응의 비발생, 의도적 치료 집단에 있어서 53%의 완전 상처 폐쇄율, 프로토콜 준수 집단에 있어서 100%의 폐쇄율 등의 3개의 현저한 성과를 나타내, 그 안전성, 효능 및 확장성을 강조했습니다. 이러한 진보로 줄기세포 상처 치료 시장은 보다 빠르고 안정적이며 접근하기 쉬운 치료 옵션으로 전환하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 줄기세포 상처 치료 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 줄기세포 상처 치료 시장 : 성장률 분석
세계의 줄기세포 상처 치료 시장 실적 : 규모 및 성장(2019-2024년)
세계의 줄기세포 상처 치료 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 줄기세포 상처 치료 시장 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 줄기세포 상처 치료 시장 : 제품 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
자기 유래
동종이식
세계의 줄기세포 상처 치료 시장 : 세포 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
중간엽 줄기세포
조혈 줄기세포
지방 유래 줄기세포
배아 줄기세포
유도 다능성 줄기세포
세계의 줄기세포 상처 치료 시장 : 상처 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
만성 상처
외과적 상처
당뇨병성 발궤양
세계의 줄기세포 상처 치료 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
피부 재생
조직 복구
혈관 신생
세계의 줄기세포 상처 치료 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원
클리닉
연구기관
재택 치료 환경
제약 기업
세계의 줄기세포 상처 치료 시장 : 자기유래 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
말초혈 줄기세포
골수 줄기세포
지방조직 줄기세포
혈소판 농축 혈장 유래 줄기세포
세계의 줄기세포 상처 치료 시장 : 동종이식 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제대 줄기세포
골수 줄기세포
태반 줄기세포
유도 다능성 줄기세포
제7장 지역별 및 국가별 분석
세계의 줄기세포 상처 치료 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 줄기세포 상처 치료 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
줄기세포 상처 치료 시장 : 경쟁 구도
줄기세포 상처 치료 시장 : 기업 프로파일
Smith & Nephew plc : 개요, 제품 및 서비스, 전략 및 재무 분석
Organogenesis Holdings Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Avita Medical Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Aroa Biosurgery Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
VIVEX Biologics Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Stempeutics Research Pvt. Ltd.
CellResearch Corporation
Histocell SL
RHEACELL GmbH & Co. KG
BioXcellerator
InGeneron Inc.
BioLab Holdings
Healiva AG
PolarityBio Inc.
Aposcience AG
StemiGenn Therapeutics Pte. Ltd.
OCT Therapies & Research
Corestem Chemon
Blue Cell Therapeutics
Chiron Therapeutics Inc.
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
줄기세포 상처 치료 시장(2009년) : 새로운 기회를 제공하는 국가
줄기세포 상처 치료 시장(2009년) : 새로운 기회를 제공하는 부문
줄기세포 상처 치료 시장(2009년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Stem cell wound therapy refers to the medical approach of using stem cells to treat or manage chronic or acute wounds by regenerating, repairing, or replacing damaged skin and underlying tissues. It is widely used in clinical research and regenerative medicine to accelerate wound healing, reduce the risk of infection, and improve overall recovery outcomes.
The primary product types in stem cell wound therapy are autologous and allogeneic treatments. Autologous therapies involve using stem cells derived from the patient's own body, such as peripheral blood, bone marrow, or adipose tissue. The primary cell types used in these therapies include mesenchymal stem cells, hematopoietic stem cells, adipose-derived stem cells, embryonic stem cells, and induced pluripotent stem cells. Stem cell wound therapies are applied across various wound types, including chronic wounds, surgical wounds, and diabetic foot ulcers, and support applications such as skin regeneration, tissue repair, and vascularization. These therapies are utilized by a range of end users, including hospitals, clinics, research institutes, home care settings, and pharmaceutical companies.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The stem cell wound therapy market research report is one of a series of new reports from The Business Research Company that provides stem cell wound therapy market statistics, including the stem cell wound therapy industry global market size, regional shares, competitors with the stem cell wound therapy market share, detailed stem cell wound therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the stem cell wound therapy industry. This stem cell wound therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The stem cell wound therapy market size has grown rapidly in recent years. It will grow from $4.01 billion in 2024 to $4.46 billion in 2025 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be linked to the rising prevalence of chronic wounds, increasing awareness of regenerative therapies, growing demand for advanced wound care products, rising geriatric population, and growing healthcare expenditure.
The stem cell wound therapy market size is expected to see rapid growth in the next few years. It will grow to $6.78 billion in 2029 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be driven by rising adoption of stem cell-based therapies, growing investment in regenerative medicine, increasing collaborations and partnerships, rising technological innovations in cell therapy, and growing focus on personalized medicine. Major trends in the forecast period include technological advancements in stem cell delivery systems, innovations in biomaterials for wound healing, development of scaffold-based therapies, research and development in synthetic stem cells, and advancements in automated stem cell manufacturing.
The rising incidence of chronic diseases is expected to drive growth in the stem cell wound therapy market. Chronic diseases are long-lasting conditions that typically progress slowly and often require ongoing medical care or limit daily activities. The increasing prevalence of these conditions is largely driven by aging populations, as older individuals are more susceptible to health complications due to weakened immunity and cumulative exposure to risk factors. Stem cell wound therapies address this growing healthcare need by offering regenerative solutions for wounds that fail to heal under standard care. For example, in April 2025, the International Diabetes Federation (IDF), a Belgium-based non-profit organization, reported that 589 million people were living with diabetes in 2024, with projections estimating an increase to 853 million by 2050. Consequently, the growing burden of chronic diseases is propelling the stem cell wound therapy market.
Leading companies are developing innovative allogeneic stem cell therapies to accelerate wound healing, improve tissue regeneration, and reduce complications associated with chronic wounds. Allogeneic therapies use donor-derived or lab-engineered stem cells, which can be produced in advance, stored, and administered to multiple patients without requiring patient-specific cell harvesting. For instance, in April 2025, Cytora Limited, a UK-based clinical-stage biotechnology company, reported successful results from its Phase 1/2a clinical trial of hOMSC200, an off-the-shelf allogeneic stem cell therapy for diabetic foot ulcers. The therapy demonstrated three notable outcomes: no immune response in recipients, a 53% complete wound closure rate in the intent-to-treat population, and a 100% closure rate in the per-protocol group, highlighting its safety, efficacy, and scalability. These advancements are helping the stem cell wound therapy market move toward faster, more reliable, and accessible treatment options.
In May 2025, AOP Health, an Austria-based healthcare technology company, partnered with RHEACELL GmbH & Co. KG to advance stem cell therapies for chronic wounds and rare diseases, including epidermolysis bullosa and chronic venous ulcers. Through this collaboration, AOP Health leverages its commercialization expertise alongside RHEACELL's late-stage stem cell research to deliver breakthrough regenerative therapies. RHEACELL, a Germany-based biopharmaceutical company, specializes in developing innovative stem cell therapies for severe inflammatory and immune-related conditions, further strengthening the market's pipeline for chronic wound treatments.
Major companies operating in the stem cell wounds therapy market are Smith & Nephew plc, Organogenesis Holdings Inc., Avita Medical Inc., Aroa Biosurgery Ltd., VIVEX Biologics Inc., Stempeutics Research Pvt. Ltd., CellResearch Corporation, Histocell S.L., RHEACELL GmbH & Co. KG, BioXcellerator, InGeneron Inc., BioLab Holdings, Healiva AG, PolarityBio Inc., Aposcience AG, StemiGenn Therapeutics Pte. Ltd., OCT Therapies & Research, Corestem Chemon, Blue Cell Therapeutics, Chiron Therapeutics Inc.
North America was the largest region in the stem cell wounds therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in stem cell wounds therapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the stem cell wounds therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The stem cell wound therapy market includes revenues earned by entities through stem cell isolation, cell culture and expansion, scaffold preparation, cell delivery and implantation, wound assessment and monitoring, and post-treatment follow-up care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Stem Cell Wounds Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on stem cell wounds therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for stem cell wounds therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The stem cell wounds therapy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Autologous; Allogeneic
3. Stem Cell Wounds Therapy Market Trends And Strategies
4. Stem Cell Wounds Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Stem Cell Wounds Therapy Growth Analysis And Strategic Analysis Framework
5.1. Global Stem Cell Wounds Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Stem Cell Wounds Therapy Market Growth Rate Analysis
5.4. Global Stem Cell Wounds Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Stem Cell Wounds Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Stem Cell Wounds Therapy Total Addressable Market (TAM)
6. Stem Cell Wounds Therapy Market Segmentation
6.1. Global Stem Cell Wounds Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Autologous
Allogeneic
6.2. Global Stem Cell Wounds Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mesenchymal Stem Cells
Hematopoietic Stem Cells
Adipose-Derived Stem Cells
Embryonic Stem Cells
Induced Pluripotent Stem Cells
6.3. Global Stem Cell Wounds Therapy Market, Segmentation By Wound Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chronic Wounds
Surgical Wound
Diabetic Foot Ulcer
6.4. Global Stem Cell Wounds Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Skin Regeneration
Tissue Repair
Vascularization
6.5. Global Stem Cell Wounds Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Research Institutes
Home Care Settings
Pharmaceutical Companies
6.6. Global Stem Cell Wounds Therapy Market, Sub-Segmentation Of Autologous, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Peripheral Blood Stem Cells
Bone Marrow Stem Cells
Adipose Tissue Stem Cells
Platelet Rich Plasma Derived Stem Cells
6.7. Global Stem Cell Wounds Therapy Market, Sub-Segmentation Of Allogeneic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Umbilical Cord Stem Cells
Bone Marrow Stem Cells
Placental Stem Cells
Induced Pluripotent Stem Cells
7. Stem Cell Wounds Therapy Market Regional And Country Analysis
7.1. Global Stem Cell Wounds Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Stem Cell Wounds Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
